BridgeBio Pharma director Jennifer E. Cook reports disposal of common shares worth $13.1 million - BBIO News | RalliesBridgeBio Pharma director Jennifer E. Cook reports disposal of common shares worth $13.1 million
B
BBIO• Director reports option exercises and share sales
- BridgeBio Pharma director Jennifer E. Cook reported option exercises, acquiring 148,589 common shares on July 9, 2026.
- Cook also sold 148,589 shares the same day at prices of USD 84 and USD 90.
- Her direct ownership ended at 8,383 shares following the transactions.
